Journal of Gastric Cancer

The Korean Gastric Cancer Association (대한위암학회)
권호 표지
DOI QR코드

DOI QR Code

Hepatic Resection for Hepatic Metastases from Gastric Adenocarcinoma

  • Baek, Hyoung-Un (Department of Surgery, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences) ;
  • Kim, Sang Bum (Department of Surgery, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences) ;
  • Cho, Eung-Ho (Department of Surgery, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences) ;
  • Jin, Sung-Ho (Department of Surgery, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences) ;
  • Yu, Hang Jong (Department of Surgery, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences) ;
  • Lee, Jong-Inn (Department of Surgery, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences) ;
  • Bang, Ho-Yoon (Department of Surgery, Konkuk University Hospital) ;
  • Lim, Chang-Sup (Department of Surgery, Dongnam Institute of Radiological and Medical Sciences)
  • Received : 2013.01.17
  • Accepted : 2013.04.22
  • Published : 2013.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: The effects of hepatic resection on patients with metastatic tumors from gastric adenocarcinomas are unclear. Therefore, we analyzed early clinical outcomes in patients who underwent surgical resection for hepatic metastases from gastric adenocarcinomas. Materials and Methods: From January 2003 to December 2010, 1,508 patients with primary gastric cancers underwent curative gastric resections at the Korea Cancer Center Hospital. Of these patients, 12 with liver-only metastases underwent curative hepatic resection. Their clinical data were analyzed retrospectively. Results: The median follow-up period was 12.5 months (range, 1~85 months); no operative mortalities or major complications were observed. Three patients underwent synchronous resections, and 9 underwent metachronous resections. In the latter group, the median interval between gastrectomy and hepatectomy for hepatic metastasis was 10.5 months (range, 5~47 months). The overall 1- and 5-year survival rates of these 12 patients were 65% and 39%, respectively, with a median overall survival of 31.0 months; 2 patients survived for >5 years. Conclusions: Hepatic resection can be a feasible procedure for treating hepatic metastases from gastric adenocarcinomas. Although this study was small and involved only selected cases, the outcomes of the hepatic resections were comparable and long-term (>5 years) survivors were identified. Surgical resection of the liver can be considered a feasible option in managing hepatic metastases from gastric adenocarcinomas.

Keywords

References

  1. Marrelli D, Roviello F, De Stefano A, Fotia G, Giliberto C, Garosi L, et al. Risk factors for liver metastases after curative surgical procedures for gastric cancer: a prospective study of 208 patients treated with surgical resection. J Am Coll Surg 2004;198:51-58. https://doi.org/10.1016/j.jamcollsurg.2003.08.013
  2. Ochiai T, Sasako M, Mizuno S, Kinoshita T, Takayama T, Kosuge T, et al. Hepatic resection for metastatic tumours from gastric cancer: analysis of prognostic factors. Br J Surg 1994;81:1175-1178. https://doi.org/10.1002/bjs.1800810832
  3. Saiura A, Umekita N, Inoue S, Maeshiro T, Miyamoto S, Matsui Y, et al. Clinicopathological features and outcome of hepatic resection for liver metastasis from gastric cancer. Hepatogastroenterology 2002;49:1062-1065.
  4. Zacherl J, Zacherl M, Scheuba C, Steininger R, Wenzl E, Mühlbacher F, et al. Analysis of hepatic resection of metastasis originating from gastric adenocarcinoma. J Gastrointest Surg 2002;6:682-689. https://doi.org/10.1016/S1091-255X(01)00075-0
  5. Okano K, Maeba T, Ishimura K, Karasawa Y, Goda F, Wakabayashi H, et al. Hepatic resection for metastatic tumors from gastric cancer. Ann Surg 2002;235:86-91. https://doi.org/10.1097/00000658-200201000-00011
  6. Sakamoto Y, Ohyama S, Yamamoto J, Yamada K, Seki M, Ohta K, et al. Surgical resection of liver metastases of gastric cancer: an analysis of a 17-year experience with 22 patients. Surgery 2003;133:507-511. https://doi.org/10.1067/msy.2003.147
  7. Koga R, Yamamoto J, Ohyama S, Saiura A, Seki M, Seto Y, et al. Liver resection for metastatic gastric cancer: experience with 42 patients including eight long-term survivors. Jpn J Clin Oncol 2007;37:836-842. https://doi.org/10.1093/jjco/hym113
  8. Sakamoto Y, Sano T, Shimada K, Esaki M, Saka M, Fukagawa T, et al. Favorable indications for hepatectomy in patients with liver metastasis from gastric cancer. J Surg Oncol 2007;95:534-539. https://doi.org/10.1002/jso.20739
  9. Cheon SH, Rha SY, Jeung HC, Im CK, Kim SH, Kim HR, et al. Survival benefit of combined curative resection of the stomach (D2 resection) and liver in gastric cancer patients with liver metastases. Ann Oncol 2008;19:1146-1153. https://doi.org/10.1093/annonc/mdn026
  10. Koga S, Kawaguchi H, Kishimoto H, Tanaka K, Miyano Y, Kimura O, et al. Therapeutic significance of noncurative gastrectomy for gastric cancer with liver metastasis. Am J Surg 1980;140:356-359. https://doi.org/10.1016/0002-9610(80)90167-1
  11. Okuyama K, Isono K, Juan IK, Onoda S, Ochiai T, Yamamoto Y, et al. Evaluation of treatment for gastric cancer with liver metastasis. Cancer 1985;55:2498-2505. https://doi.org/10.1002/1097-0142(19850515)55:10<2498::AID-CNCR2820551032>3.0.CO;2-S
  12. Ambiru S, Miyazaki M, Ito H, Nakagawa K, Shimizu H, Yoshidome H, et al. Benefits and limits of hepatic resection for gastric metastases. Am J Surg 2001;181:279-283. https://doi.org/10.1016/S0002-9610(01)00567-0
  13. Shirabe K, Shimada M, Matsumata T, Higashi H, Yakeishi Y, Wakiyama S, et al. Analysis of the prognostic factors for liver metastasis of gastric cancer after hepatic resection: a multiinstitutional study of the indications for resection. Hepatogastroenterology 2003;50:1560-1563.
  14. Bines SD, England G, Deziel DJ, Witt TR, Doolas A, Roseman DL. Synchronous, metachronous, and multiple hepatic resections of liver tumors originating from primary gastric tumors. Surgery 1993;114:799-805.
  15. Hirai I, Kimura W, Fuse A, Isobe H, Hachiya O, Moriya T, et al. Surgical management for metastatic liver tumors. Hepatogastroenterology 2006;53:757-763.
  16. Miyazaki M, Itoh H, Nakagawa K, Ambiru S, Shimizu H, Togawa A, et al. Hepatic resection of liver metastases from gastric carcinoma. Am J Gastroenterol 1997;92:490-493.
  17. Roh HR, Suh KS, Lee HJ, Yang HK, Choe KJ, Lee KU. Outcome of hepatic resection for metastatic gastric cancer. Am Surg 2005;71:95-99.
  18. Fujii K, Fujioka S, Kato K, Machiki Y, Kutsuna Y, Ishikawa A, et al. Resection of liver metastasis from gastric adenocarcinoma. Hepatogastroenterology 2001;48:368-371.
  19. Nakamura S, Suzuki S, Baba S. Resection of liver metastases of colorectal carcinoma. World J Surg 1997;21:741-747. https://doi.org/10.1007/s002689900300
  20. Cady B, Stone MD, McDermott WV Jr, Jenkins RL, Bothe A Jr, Lavin PT, et al. Technical and biological factors in disease-free survival after hepatic resection for colorectal cancer metastases. Arch Surg 1992;127:561-568. https://doi.org/10.1001/archsurg.1992.01420050085011
  21. Kazemier G. Unresectable colorectal cancer liver metastases treated by intraoperative radiofrequency ablation with or without resection (Br J Surg 2012; 99: 558-565). Br J Surg 2012;99:566. https://doi.org/10.1002/bjs.8724
  22. Cheung TT, Ng KK, Chok KS, Chan SC, Poon RT, Lo CM, et al. Combined resection and radiofrequency ablation for multifocal hepatocellular carcinoma: prognosis and outcomes. World J Gastroenterol 2010;16:3056-3062. https://doi.org/10.3748/wjg.v16.i24.3056

Cited by

  1. Surgery for recurrent biliary carcinoma: results for 27 recurrent cases vol.13, pp.None, 2013, https://doi.org/10.1186/s12957-015-0507-8
  2. Hepatic resection for gastric cancer liver metastases: A systematic review and meta‐analysis vol.111, pp.8, 2013, https://doi.org/10.1002/jso.23920
  3. Liver-directed treatments for liver metastasis from gastric adenocarcinoma: comparison between liver resection and radiofrequency ablation vol.19, pp.3, 2016, https://doi.org/10.1007/s10120-015-0522-z
  4. Systematic review of partial hepatic resection to treat hepatic metastases in patients with gastric cancer vol.95, pp.44, 2013, https://doi.org/10.1097/md.0000000000005235
  5. Influence of Surgical Resection of Hepatic Metastases From Gastric Adenocarcinoma on Long-term Survival: Systematic Review and Pooled Analysis vol.263, pp.6, 2013, https://doi.org/10.1097/sla.0000000000001542
  6. Proton beam therapy for liver metastases from gastric cancer vol.58, pp.3, 2013, https://doi.org/10.1093/jrr/rrw102
  7. Surgical resection for hepatic metastasis from gastric cancer: a multi- institution study vol.8, pp.41, 2013, https://doi.org/10.18632/oncotarget.16705
  8. Hepatectomy for liver metastases from gastric cancer: a systematic review vol.17, pp.None, 2013, https://doi.org/10.1186/s12893-017-0215-0
  9. Long-term Survival after Repeated Local Therapy and Salvage Chemotherapy for Recurrent Metastases from Gastric Cancer: a Case Report and Literature Review vol.18, pp.3, 2018, https://doi.org/10.5230/jgc.2018.18.e26
  10. SHCBP1 is a novel target and exhibits tumor-promoting effects in gastric cancer vol.41, pp.3, 2013, https://doi.org/10.3892/or.2018.6952
  11. Outcomes of surgical resection for gastric cancer liver metastases: a retrospective analysis vol.18, pp.None, 2020, https://doi.org/10.1186/s12957-020-01816-9
  12. Identifying Optimal Surgical Intervention-Based Chemotherapy for Gastric Cancer Patients With Liver Metastases vol.11, pp.None, 2013, https://doi.org/10.3389/fonc.2021.675870
  13. Efficacy of Surgery for the Treatment of Gastric Cancer Liver Metastases: A Systematic Review of the Literature and Meta-Analysis of Prognostic Factors vol.10, pp.5, 2013, https://doi.org/10.3390/jcm10051141
  14. Surgical treatment of gastric cancer liver metastases: Systematic review and meta-analysis of long-term outcomes and prognostic factors vol.163, pp.None, 2013, https://doi.org/10.1016/j.critrevonc.2021.103313